Cargando…
Tetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent Autophagy
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the accumulation of amyloid-β (Aβ) peptide. We have previously shown that the compound tetrahydrohyperforin (IDN5706) prevents accumulation of Aβ species in an in vivo model of AD, however the mechanism that explains this...
Autores principales: | Cavieres, Viviana A., González, Alexis, Muñoz, Vanessa C., Yefi, Claudia P., Bustamante, Hianara A., Barraza, Rafael R., Tapia-Rojas, Cheril, Otth, Carola, Barrera, María José, González, Carlos, Mardones, Gonzalo A., Inestrosa, Nibaldo C., Burgos, Patricia V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550396/ https://www.ncbi.nlm.nih.gov/pubmed/26308941 http://dx.doi.org/10.1371/journal.pone.0136313 |
Ejemplares similares
-
Tetrahydrohyperforin (IDN5706) targets the endoplasmic reticulum for autophagy activation: potential mechanism for Alzheimer's disease therapy
por: González, Alexis, et al.
Publicado: (2016) -
Tetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease
por: Montecinos-Oliva, Carla, et al.
Publicado: (2015) -
Turnover of C99 is Controlled by a Crosstalk between ERAD and Ubiquitin-Independent Lysosomal Degradation in Human Neuroglioma Cells
por: Bustamante, Hianara A., et al.
Publicado: (2013) -
Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer's disease
por: Tapia-Rojas, Cheril, et al.
Publicado: (2018) -
Interplay Between the Autophagy-Lysosomal Pathway and the Ubiquitin-Proteasome System: A Target for Therapeutic Development in Alzheimer’s Disease
por: Bustamante, Hianara A., et al.
Publicado: (2018)